RNS Number : 7877D
JPMorgan UK Small Cap Grwth&Inc PLC
11 September 2024
| JPMORGAN UK SMALL CAP GROWTH & INCOME PLC (the 'Company') |
|
| Legal Entity Identifier: 549300PXALXKUMU9JM18 | |
| THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 August 2024 | |
| Ashtead Plc | 4.4% |
| Premier Foods Plc | 3.9% |
| Bank Of Georgia Plc | 3.5% |
| Warpaint London Plc | 3.4% |
| Jet2 Plc | 3.3% |
| 4Imprint Group Plc | 2.7% |
| Alpha Fx Group Plc | 2.6% |
| Cerillion Plc | 2.5% |
| Xps Pensions Group Plc | 2.2% |
| Keller Group Plc | 2.1% |
| Total | 30.7% |
| Excludes Investments in Liquidity stocks | |
| Name of contact and telephone number for queries: | |
| Paul Ainger 0044 207 742 6524 | |
| Name of authorised company official responsible for making this notification: | |
| Lucy Dina 0044 207 742 3735 - Company Secretary | |
| Date: 11 September 2024 |
|
| | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.